Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 5/20 | 0.39 |
| ▸ | MECP2 | P51608 | 1/20 | 0.39 |
| ▸ | MBD2 | Q9UBB5 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31478323 | 0.94 | HTT (0.46) | ALDH1A1HPGDKDM4EHTTMEN1 | |
| SCHEMBL9392792 | 0.92 | HTT (0.49) | ALDH1A1HPGDKDM4EHTTMEN1 | |
| SCHEMBL762232 | 0.88 | ALDH1A1 (0.46) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL10766403 | 0.87 | ALDH1A1 (0.42) | ALDH1A1HPGDKDM4EHTTMEN1 | |
| SCHEMBL25236869 | 0.84 | ALDH1A1 (0.50) | ALDH1A1HPGDKDM4EHTTMEN1 | |
| SCHEMBL26112310 | 0.84 | ALDH1A1 (0.41) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL8244852 | 0.84 | ALDH1A1 (0.41) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL31478134 | 0.84 | ALDH1A1 (0.41) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL10761288 | 0.81 | NISCH (0.41) | ALDH1A1POLB | |
| SCHEMBL9424760 | 0.80 | KIF11 (0.44) | ALDH1A1NPSR1CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5073558-A | AMINOPYRIMIDINE DERIVATIVE AND INSECTICIDE OR BACTERICIDE CONTAINING THE DERIVATIVE | UBE INDUSTRIES, LTD. (JP) | 1991-12-17 | — | — | US | claimed |
| US-20250263367-A1 | A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2025-08-21 | — | — | US | disclosed |
| US-20250248973-A1 | CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF | CORBUS PHARMACEUTICALS, INC. | 2025-08-07 | — | — | US | disclosed |
| US-12286405-B2 | Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-04-29 | — | — | US | disclosed |
| WO-2025040089-A1 | NOVEL HETEROCYCLIC COMPOUND FOR SELECTIVELY REGULATING CANNABINOID CB1 FUNCTION | 德睿智药(苏州)新药研发有限公司 | 2025-02-27 | — | — | WO | disclosed |
| EP-4504179-A1 | CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF | Corbus Pharmaceuticals, Inc. (US) | 2025-02-12 | — | — | EP | disclosed |
| CN-119325378-A | Cannabinoid receptor 1 antagonists/inverse agonists and uses thereof | 柯巴斯医药有限公司 | 2025-01-17 | — | — | CN | disclosed |
| EP-3423448-B1 | CANNABINOID RECEPTOR MEDIATING COMPOUNDS | US HEALTH (US) | 2024-12-04 | — | — | EP | disclosed |
| EP-4341246-A1 | A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2024-03-27 | — | — | EP | disclosed |
| US-11939297-B2 | Cannabinoid receptor mediating compounds | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-03-26 | — | — | US | disclosed |
| WO-1995016676-A1 | ARTHROPODICIDAL PENTAFLUOROTHIO SUBSTITUTED ANILIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-06-22 | — | — | WO | disclosed |
| EP-0153127-B1 | N-ARYL-3-ARYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDES, PROCESSES FOR THEIR PRODUCTION, INSECTICIDAL COMPOSITIONS CONTAINING THEM AND METHODS FOR COMBATTING INSECTS | ROHM AND HAAS COMPANY (US) | 1991-04-03 | — | — | EP | disclosed |
| US-4863947-A | PESTICIDES, INSECTICIDES | ROHM AND HAAS (US) | 1989-09-05 | — | — | US | disclosed |
| US-4767779-A | Pyrazoline-1-carboxamides, composition containing them, and insecticidal method of using them | FMC CORPORATION (US) | 1988-08-30 | — | — | US | disclosed |
| US-4663341-A | Insecticidal n-aryl-3-aryl-4,5-dihydro-1h-pyrazole-1-carboxamides | ROHM AND HAAS COMPANY (US) | 1987-05-05 | — | — | US | disclosed |
| CN-85107882-A | Preparation method for pyrazolines | — | 1986-06-10 | — | — | CN | disclosed |
| US-4572914-A | Insecticidal 4-substituted-3-chlorophenyl-1-(fluoroalkoxyphenylcarbamoyl)pyrazolines | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1986-02-25 | — | — | US | disclosed |
| EP-0153127-A2 | N-aryl-3-aryl-4,5-dihydro-1H-pyrazole-1-carboxamides, processes for their production, insecticidal compositions containing them and methods for combatting insects | ROHM AND HAAS COMPANY (US) | 1985-08-28 | — | — | EP | disclosed |
| EP-0021506-B1 | NEW PYRAZOLINE DERIVATIVES, METHOD OF PREPARING THE NEW COMPOUNDS, AS WELL AS INSECTICIDAL COMPOSITION ON THE BASIS OF THESE NEW COMPOUNDS | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1983-09-07 | — | — | EP | disclosed |
| EP-0021506-A2 | New pyrazoline derivatives, method of preparing the new compounds, as well as insecticidal composition on the basis of these new compounds | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1981-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250248973-A1 | CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF | CNR1, CNR2, GPR119 | ALDH1A1 2140/4885HPGD 991/4885KDM4E 2960/4885 |
| US-12286405-B2 | Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase | CNR1, CNR2, NOS1 | ALDH1A1 425/4885HPGD 134/4885KDM4E 1434/4885 |
| US-20250263367-A1 | A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES | TAS2R40, TAS2R10, TAS2R9 | ALDH1A1 2544/4885HPGD 3694/4885KDM4E 769/4885 |
| US-11939297-B2 | Cannabinoid receptor mediating compounds | CNR1, CNR2, GPR18 | ALDH1A1 3508/4885HPGD 3470/4885KDM4E 2473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.